Genetic Polymorphisms of Angiotensin Converting Enzyme (I/D) and Endothelial Nitric Oxide Synthase (T(-788)C) Genes in Japanese Patients with Myocardial Infarction
暂无分享,去创建一个
[1] J. Vermylen,et al. The ATP-Gated P2X1 Ion Channel Acts as a Positive Regulator of Platelet Responses to Collagen , 2001, Thrombosis and Haemostasis.
[2] C. Gachet,et al. Differential Involvement of the P2Y1 and P2YT Receptors in the Morphological Changes of Platelet Aggregation , 2001, Thrombosis and Haemostasis.
[3] T. Ogihara,et al. T+31C Polymorphism of Angiotensinogen Gene and Essential Hypertension , 2001, Hypertension.
[4] C. Brearley,et al. Platelet Shape Change Evoked by Selective Activation of P2X1 Purinoceptors with α,β-Methylene ATP , 2001, Thrombosis and Haemostasis.
[5] R. Evans,et al. ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets , 2000, British journal of pharmacology.
[6] J. Vermylen,et al. A Natural Dominant Negative P2X1 Receptor Due to Deletion of a Single Amino Acid Residue* , 2000, The Journal of Biological Chemistry.
[7] G. Burnstock,et al. Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors , 2000, Drug development research.
[8] T. Ogihara,et al. Human prostacyclin synthase gene and hypertension : the Suita Study. , 1999, Circulation.
[9] Sarah Parish,et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls , 1999, The Lancet.
[10] C. Gachet,et al. ADP receptors and clinical bleeding disorders. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[11] K. Nakao,et al. T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.
[12] Herrmann,et al. Polymorphisms of the endothelial nitric oxide synthase gene — no consistent association with myocardial infarction in the ECTIM study , 1999, European journal of clinical investigation.
[13] G Burnstock,et al. Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.
[14] T. K. Harden,et al. Identification of competitive antagonists of the P2Y1 receptor. , 1996, Molecular pharmacology.
[15] P. Stanssens,et al. An echistatin‐like Arg‐Gly‐Asp (RGD)‐containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function , 1994, British journal of haematology.
[16] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.